what was the first glp-1 agonist Frontiers GLP-1 Agonists - What is
Description
Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain
Credits: istock.org
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.
Limited evidence suggests that combined SGLT2is/GLP1-RAs therapy can potentially improve most but not all outcomes
Indias pharma industry is strong
Discover the U.S
